Disruption of the 5-lipoxygenase pathway attenuates atherogenesis consequent to COX-2 deletion in mice.
about
The role of lipoxygenases in pathophysiology; new insights and future perspectivesVascular COX-2 modulates blood pressure and thrombosis in mice.Myeloid cell microsomal prostaglandin E synthase-1 fosters atherogenesis in mice.COX-2 protects against atherosclerosis independently of local vascular prostacyclin: identification of COX-2 associated pathways implicate Rgl1 and lymphocyte networks.LC-MS/MS confirms that COX-1 drives vascular prostacyclin whilst gene expression pattern reveals non-vascular sites of COX-2 expressionThe adverse effect of selective cyclooxygenase-2 inhibitor on random skin flap survival in rats.Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular system.PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.Timing of expression of the core clock gene Bmal1 influences its effects on aging and survival.Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokersCardiovascular Consequences of Prostanoid I Receptor Deletion in Microsomal Prostaglandin E Synthase-1-Deficient Hyperlipidemic Mice.Cyclooxygenase-2 in endothelial and vascular smooth muscle cells restrains atherogenesis in hyperlipidemic mice.Molecular biology of atherosclerosis.Cardiovascular disease and non-steroidal anti-inflammatory drug prescribing in the midst of evolving guidelines.Myeloid cell 5-lipoxygenase activating protein modulates the response to vascular injury.Targeting leukotriene B4 in inflammation.Prostaglandin E2 promotes hepatic bile acid synthesis by an E prostanoid receptor 3-mediated hepatocyte nuclear receptor 4α/cholesterol 7α-hydroxylase pathway in mice.
P2860
Q26795652-C94D03F8-D43E-44DF-B6E7-4741AFE3AB5EQ30562262-429702B3-870C-4334-8691-14CAC3253BEEQ33607097-8F0CB550-06BD-42F1-8821-379D680135EFQ33699097-B7B8610A-FDC7-49A5-83FF-2FA0761E09F6Q34854231-1BC755AF-00F6-4C2A-B041-CB3A2EEECA43Q35064306-D2FED5B6-BC6B-458D-A84D-2DF76383777FQ36378519-C37D8EFA-8C27-4B77-A997-29E74A5FA6B2Q36624751-D48652B7-C474-4910-A74A-10723F74D943Q36909030-08352EFF-BDFD-4DB6-BFEB-C9E1231DEA7BQ36999615-2B739335-E5FF-4435-B604-33FF3ACBCE94Q37131539-08B9423A-C8DA-4E32-BB2E-8A2DD4726332Q37735500-66333274-BCC4-4A90-ACD8-2B6C346D2641Q38125279-6FF715BD-F942-48CA-BCBC-C69CA0F174F8Q38429068-327FE265-D2C1-4F0C-833C-0DD3590F0191Q41760870-116E69EB-85EA-4B92-AF3C-5CC0270A5284Q43464822-DED75364-4715-4576-ADEF-7B82E4F8891BQ48883205-66F48A0B-524E-45AE-A8A4-D64FDDC6BDF2
P2860
Disruption of the 5-lipoxygenase pathway attenuates atherogenesis consequent to COX-2 deletion in mice.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Disruption of the 5-lipoxygena ...... ent to COX-2 deletion in mice.
@ast
Disruption of the 5-lipoxygena ...... ent to COX-2 deletion in mice.
@en
type
label
Disruption of the 5-lipoxygena ...... ent to COX-2 deletion in mice.
@ast
Disruption of the 5-lipoxygena ...... ent to COX-2 deletion in mice.
@en
prefLabel
Disruption of the 5-lipoxygena ...... ent to COX-2 deletion in mice.
@ast
Disruption of the 5-lipoxygena ...... ent to COX-2 deletion in mice.
@en
P2093
P2860
P356
P1476
Disruption of the 5-lipoxygena ...... uent to COX-2 deletion in mice
@en
P2093
Ellen Puré
Emanuela Ricciotti
Garret A FitzGerald
Irene Crichton
John A Lawson
Soon Yew Tang
P2860
P304
P356
10.1073/PNAS.1115313109
P407
P50
P577
2012-04-09T00:00:00Z